New GlaxoSmithKline CEO prepares for R&D choices, potential deals
Go back to New GlaxoSmithKline CEO prepares for R&D choices, potential deals| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,873,539 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 145.65 -0.99 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.64 | 52 Week High | $108.63 | |||
| Open | $145.46 | 52 Week Low | $71.39 | |||
| Day High | $147.68 | P/E | 80.47 | |||
| Day Low | $145.00 | EPS | $1.81 | |||
| Volume | 4,582,486 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.63 +0.09 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.54 | 52 Week High | $45.58 | |||
| Open | $48.81 | 52 Week Low | $37.82 | |||
| Day High | $49.16 | P/E | N/A | |||
| Day Low | $48.60 | EPS | $0.00 | |||
| Volume | 2,405,233 | |||||
| NOVEN PHARMACEUTIC (NASDAQ: NOVN) | Delayed: 0.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $23.79 | |||
| Open | $10.12 | 52 Week Low | $13.73 | |||
| Day High | $0.09 | P/E | 0.09 | |||
| Day Low | $0.09 | EPS | $1.05 | |||
| Volume | 1,574,031 | |||||

